Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Ethyl Acetate | HCID 8857 | — |
| Reactant | 1-Methylpiperazine | HCID 53167 | — |
| Reactant | 1-Hydroxybenzotriazole | HCID 75771 | — |
| Reactant | 1,3-Propanediamine, N'-(ethylcarbonimidoyl)-N,N-dimethyl-, monohydrochloride | HCID 2723939 | — |
| Reactant | HCID 10530330 | HCID 10530330 | — |
| Solvent | Dimethylformamide | HCID 6228 | — |
| Product | HCID 9873768 | HCID 9873768 | — |
Reaction Steps
To a solution of 1-carboxymethyl-5-{4-[2-(4 -methylphenyl)benzoylamino]benzoyl}-1,3,4,5-tetrahydro -1,5-benzodiazepin-2(2H)-one (90 mg), N-methylpiperazine (17 mg) and 1-hydroxybenzotriazole (27 mg) in N,N-dimethylformamide (4 ml) was added 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (39 mg) at ambient temperature and the mixture was stirred at the same temperature for 1.5 hours. The resulting mixture was diluted with ethyl acetate and then the solution was washed with saturated sodium bicarbonate aqueous solution and brine. Drying over magnesium sulfate, filtering and the removal of solvents afforded a crude product. The crude product was triturated with a mixture of diethyl ether and n-hexane (1:1) to give 5-{4-[2-(4-methylphenyl)benzoylamino]benzoyl}-1-[(4-methyl-1-piperazinyl)carbonylmethyl]-1,3,4,5-tetrahydro-1,5-benzodiazepin-2(2H)-one (100 mg) as a white powder.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US05521170 |
|---|
| Source dataset | uspto-grants-1996_05 |
|---|
| ORD ID | ord-9fdc00e218594749986ba1c887161612 |
|---|
| Source note | uspto-grants-1996_05 |
|---|